• PLK1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-04-25

  This study uncovers how Polo-like kinase 1 (PLK1) regulates p31comet through direct phosphorylation, suppressing its ability to disassemble mitotic checkpoint complexes and thus ensuring proper mitotic checkpoint fidelity. These findings clarify a key layer of cell cycle control and provide mechanistic rationale for using selective PLK1 inhibitors to probe mitotic progression and checkpoint inactivation.

• Trichostatin A in Epigenetic Cancer Research: Protocols & In

  2026-04-24

  Trichostatin A (TSA) stands out as a robust HDAC inhibitor for precise epigenetic modulation in cancer research. This article delivers actionable workflows, troubleshooting strategies, and evidence-backed tips for maximizing TSA’s utility in cell-based and in vivo studies, drawing from recent in-depth studies and APExBIO’s trusted product quality.

• Applied Workflows with Nicotinamide Adenine Dinucleotide (NA

  2026-04-24

  Nicotinamide Adenine Dinucleotide (NAD+) empowers researchers to dissect metabolic signaling, autophagy, and DNA repair with precision. This article synthesizes the latest mechanistic insights and hands-on troubleshooting to help you design robust, reproducible experiments using APExBIO’s high-purity NAD+.

• Circ_0001944 Modulation of FXR/TLR4 and Ferroptosis in NiONP

  2026-04-23

  This study reveals how hsa_circ_0001944 mitigates nickel oxide nanoparticle (NiONP)-induced collagen deposition in hepatic stellate cells by regulating the FXR/TLR4 signaling pathway and ferroptosis. The findings provide mechanistic clarity on the interplay between non-coding RNAs, nuclear receptor signaling, and cell death pathways in liver fibrosis models.

• Tiamulin (Thiamutilin): Molecular Selectivity, Ionophore Int

  2026-04-23

  Explore the molecular mechanisms and unique ionophore interactions of Tiamulin (Thiamutilin), a leading veterinary antibiotic for pigs and poultry. Gain new insights into its clinical and experimental advantages, protocol optimization, and emerging anti-inflammatory potential.

• Viral-Mediated RIPK3 Degradation Regulates Necroptosis and I

  2026-04-22

  This study reveals how certain orthopoxviruses encode a viral inducer of RIPK3 degradation (vIRD) that hijacks the host ubiquitin-proteasome system to degrade RIPK3, thereby suppressing necroptosis and modulating virus-induced inflammation. The findings provide mechanistic insight into viral immune evasion and highlight the central role of proteasome-dependent pathways in host-pathogen interactions.

• Necrosulfonamide: Redefining Necroptosis Pathways in Transla

  2026-04-22

  This thought-leadership article explores Necrosulfonamide (NSA) as an advanced tool for dissecting necroptosis in translational models, highlighting its mechanistic specificity, strategic advantages for researchers, and implications for cardiovascular and neurodegenerative disease studies. By bridging recent mechanistic findings on cell death in ischemia–reperfusion injury with NSA's precision inhibition of MLKL, the article provides actionable guidance and protocol insights for those seeking to harness necroptosis assays in cutting-edge translational research.

• Applied Tiamulin (Thiamutilin) Workflows for Veterinary Rese

  2026-04-21

  Tiamulin (Thiamutilin) stands out as a dual-action veterinary antibiotic, enabling precise control of Mycoplasma gallisepticum and inflammation in pigs and poultry. This guide provides evidence-driven protocols, troubleshooting strategies, and advanced use-cases to maximize experimental reliability and translational impact.

• Practical Guide: GSH and GSSG Assay Kit (SKU K4630) Protocol

  2026-04-21

  The GSH and GSSG Assay Kit addresses quantitative detection of reduced and oxidized glutathione in biological samples, supporting oxidative stress and redox state research. It is suitable for animal tissues, plasma, red blood cells, and cultured cells but should not be used for unsupported sample types or for clinical diagnostics.

• Protein Quantification as a Linchpin in BBB Translational Re

  2026-04-20

  This article examines how precision protein quantification—anchored by the BCA Protein Assay Kit—empowers translational researchers to dissect and target brain endothelial pyroptosis, as revealed in recent HIV-1 gp120 blood–brain barrier (BBB) disruption studies. It integrates mechanistic insight with strategic guidance, bridging rigorous biochemical workflows to immediate clinical opportunities.

• Open-Platform DLP Enables High-Throughput Hydrogel Printing

  2026-04-20

  This study introduces an open-platform digital light printer (OP-DLP) for cost-effective, precise hydrogel synthesis in 96-well plates, overcoming longstanding challenges in gel uniformity and spatial biomolecule activation. The platform’s adaptability has broad implications for high-throughput biomaterials and cell-based assays.

• Biotin-16-UTP: Technical Guidance for RNA Labeling Workflows

  2026-04-19

  Biotin-16-UTP provides a practical solution for incorporating biotin into RNA during in vitro transcription, enabling downstream detection, purification, and interaction studies. It is best suited for controlled molecular biology workflows where specificity and compatibility with streptavidin-based detection are essential. This reagent should not be used for diagnostic or clinical applications, and special care must be taken to maintain its stability.

• Redefining Apoptosis: TNF-alpha in Non-Transcriptional Cell

  2026-04-18

  This thought-leadership article explores the transformative role of TNF-alpha recombinant murine protein in dissecting apoptosis beyond classical transcriptional loss. By integrating recent discoveries on nuclear-mitochondrial signaling and TNF receptor pathways, it provides strategic guidance for translational researchers seeking to optimize disease models and interpret cytotoxicity with greater precision.

• Analytical Advances in Rotigotine: Quality Control for Dopam

  2026-04-17

  This review critically surveys analytical methods for assessing Rotigotine and its impurities in both raw materials and transdermal formulations. By comparing pharmacopoeial standards and recent literature, the study highlights the importance of robust impurity profiling and chiral purity assessment to improve the safety and efficacy of this dopamine D2/D3 receptor agonist in Parkinson’s disease research.

• AO/PI Staining Solution: Precision in Fluorescent Cell Count

  2026-04-16

  AO/PI Staining Solution offers a leap over traditional viability assays, providing scientists with robust, interference-free live/dead cell discrimination using dual fluorescent DNA dyes. This article details optimized workflows, application scenarios, and troubleshooting strategies, bridging recent advances in disease modeling with actionable assay enhancements.

15811 records 1/1055 page Next 12345 下5页 Last page